You are here

  • Home
  • Archive
  • Volume 67, Issue 8
  • Pretreatment serum levels of anti-cyclic citrullinated peptide antibodies are associated with the response to methotrexate in recent-onset arthritis

Article info

Article menu
Download PDFPDF
Letter
Pretreatment serum levels of anti-cyclic citrullinated peptide antibodies are associated with the response to methotrexate in recent-onset arthritis

Authors

  1. Miss K Visser, Leiden University Medical Centre, Department of Rheumatology, PO Box 9600, 2300 RC Leiden, The Netherlands; K.Visser{at}lumc.nl
View Full Text

Citation

Visser K, Verpoort KN, van Dongen H, et al
Pretreatment serum levels of anti-cyclic citrullinated peptide antibodies are associated with the response to methotrexate in recent-onset arthritis
Annals of the Rheumatic Diseases 2008;67:1194-1195.

Publication history

  • Accepted January 14, 2008
  • First published July 11, 2008.
Online issue publication 
April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2008 BMJ Publishing Group and European League Against Rheumatism